Page last updated: 2024-11-10

viomycin

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth

Cross-References

ID SourceID
PubMed CID135398671
CHEMBL ID3085436
CHEBI ID15782
SCHEMBL ID34586
MeSH IDM0022690

Synonyms (38)

Synonym
(3s)-3,6-diamino-n-[(3s,6z,9s,12s,15s)-6-{[(aminocarbonyl)amino]methylidene}-3-[(4r,6s)-2-amino-6-hydroxy-3,4,5,6-tetrahydropyrimidin-4-yl]-9,12-bis(hydroxymethyl)-2,5,8,11,14-pentaoxo-1,4,7,10,13-pentaazacyclohexadecan-15-yl]hexanamide
celiomycin
viomycin (vm)
(3s)-3,6-diamino-n-[(3s,6z,9s,12s,15s)-3-[(4r,6s)-6-hydroxy-2-imino-hexahydropyrimidin-4-yl]-9,12-bis(hydroxymethyl)-2,5,8,11,14-pentaoxo-6-(ureidomethylene)-1,4,7,10,13-pentazacyclohexadec-15-yl]hexanamide
37883-00-4
florimycin
tuberactinomycin b
AB00514055
VIOMYCIN ,
C01540
32988-50-4
viomicina [inn-spanish]
viomicina [italian]
vioactane
viomycine [inn-french]
viomycinum [inn-latin]
einecs 251-323-0
floromycin
vinacetin a
viomycine
viomycinum
CHEBI:15782 ,
(3s)-3,6-diamino-n-[(3s,6z,9s,12s,15s)-6-[(carbamoylamino)methylene]-3-[(4r,6s)-6-hydroxy-2-iminohexahydropyrimidin-4-yl]-9,12-bis(hydroxymethyl)-2,5,8,11,14-pentaoxo-1,4,7,10,13-pentaazacyclohexadecan-15-yl]hexanamide
viomicina
(3s)-3,6-diamino-n-[(3s,6z,9s,12s,15s)-3-[(4s,6r)-2-amino-4-hydroxy-1,4,5,6-tetrahydropyrimidin-6-yl]-6-[(carbamoylamino)methylidene]-9,12-bis(hydroxymethyl)-2,5,8,11,14-pentaoxo-1,4,7,10,13-pentazacyclohexadec-15-yl]hexanamide
unii-yvu35998k5
yvu35998k5 ,
viomycin [inn:ban]
viomycin [inn]
tuberactinomycin b [mi]
viomycin [who-dd]
glycine, 3-amino-n-((3s)-3,6-diamino-1-oxohexyl)-l-alanyl-l-seryl-l-seryl-(2z)-3-((aminocarbonyl)amino)-2,3-didehydroalanyl-2-((4r,6s)-2-amino-1,4,5,6-tetrahydro-6-hydroxy-4-pyrimidinyl)-, (5->13)-lactam, (2s)-
DB06827
SCHEMBL34586
CHEMBL3085436
DTXSID0023741
(3s)-3,6-diamino-n-[(3s,6z,9s,12s,15s)-3-[(4r,6s)-2-amino-6-hydroxy-1,4,5,6-tetrahydropyrimidin-4-yl]-6-[(carbamoylamino)methylidene]-9,12-bis(hydroxymethyl)-2,5,8,11,14-pentaoxo-1,4,7,10,13-pentazacyclohexadec-15-yl]hexanamide
HY-A0155

Research Excerpts

Dosage Studied

ExcerptRelevanceReference
"The dose-response relationships of a viomycin (VM) immunogen for total immunoglobulin (Ig) G and anti-VM antibody response of mouse using aluminum hydroxide as adjuvant was studied."( Studies on the optimal immunization schedule of experimental animals. VI. Antigen dose-response of aluminum hydroxide-aided immunization and booster effect under low antigen dose.
Hu, JG; Kitagawa, T, 1990
)
0.28
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Roles (1)

RoleDescription
antitubercular agentA substance that kills or slows the growth of Mycobacterium tuberculosis and is used in the treatment of tuberculosis.
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Drug Classes (2)

ClassDescription
peptide antibioticA chemically diverse class of peptides that exhibit antimicrobial properties.
heterodetic cyclic peptideA heterodetic cyclic peptide is a peptide consisting only of amino-acid residues, but in which the linkages forming the ring are not solely peptide bonds; one or more is an isopeptide, disulfide, ester, or other bond.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Bioassays (13)

Assay IDTitleYearJournalArticle
AID375077Binding affinity to RNA ribosome intersubuint bridge2009Journal of medicinal chemistry, Jun-25, Volume: 52, Issue:12
Design and implementation of an ribonucleic acid (RNA) directed fragment library.
AID588220Literature-mined public compounds from Kruhlak et al phospholipidosis modelling dataset2008Toxicology mechanisms and methods, , Volume: 18, Issue:2-3
Development of a phospholipidosis database and predictive quantitative structure-activity relationship (QSAR) models.
AID513827Binding affinity to Escherichia coli ribosomal pre-translocation complex assessed as decreased rate of EF-G-catalyzed translocation by tRNA at <2 uM2010Nature chemical biology, Jan, Volume: 6, Issue:1
Aminoglycoside activity observed on single pre-translocation ribosome complexes.
AID91435Inhibition against HIV-1 integrase at 1 mM2000Journal of medicinal chemistry, Jun-01, Volume: 43, Issue:11
Developing a dynamic pharmacophore model for HIV-1 integrase.
AID513831Binding affinity to Escherichia coli ribosomal pre-translocation complex assessed as stabilization of hybrid-state occupancy by tRNA at 2 uM2010Nature chemical biology, Jan, Volume: 6, Issue:1
Aminoglycoside activity observed on single pre-translocation ribosome complexes.
AID91436Inhibition against HIV-1 integrase at 200 uM2000Journal of medicinal chemistry, Jun-01, Volume: 43, Issue:11
Developing a dynamic pharmacophore model for HIV-1 integrase.
AID513828Binding affinity to Escherichia coli ribosomal pre-translocation complex assessed as stabilization of hybrid-state occupancy by tRNA at 100 nM2010Nature chemical biology, Jan, Volume: 6, Issue:1
Aminoglycoside activity observed on single pre-translocation ribosome complexes.
AID513833Binding affinity to Escherichia coli ribosomal pre-translocation complex assessed as classical-state occupancy by tRNA at 200 uM (Rvb= 62.4+/-1.1%)2010Nature chemical biology, Jan, Volume: 6, Issue:1
Aminoglycoside activity observed on single pre-translocation ribosome complexes.
AID513830Binding affinity to Escherichia coli ribosomal pre-translocation complex assessed as decreased rate of EF-G-catalyzed translocation fraction by tRNA at 100 nM2010Nature chemical biology, Jan, Volume: 6, Issue:1
Aminoglycoside activity observed on single pre-translocation ribosome complexes.
AID513825Binding affinity to Escherichia coli ribosomal pre-translocation complex assessed as stabilization of hybrid-state occupancy by tRNA at <2 uM2010Nature chemical biology, Jan, Volume: 6, Issue:1
Aminoglycoside activity observed on single pre-translocation ribosome complexes.
AID513829Binding affinity to Escherichia coli ribosomal pre-translocation complex assessed as decreased rate of EF-G-catalyzed translocation by tRNA at 100 nM2010Nature chemical biology, Jan, Volume: 6, Issue:1
Aminoglycoside activity observed on single pre-translocation ribosome complexes.
AID513837Binding affinity to Escherichia coli ribosomal pre-translocation complex assessed as tRNA translocation rate at 200 uM (Rvb= 1.57+/-0.05 /sec)2010Nature chemical biology, Jan, Volume: 6, Issue:1
Aminoglycoside activity observed on single pre-translocation ribosome complexes.
AID513826Binding affinity to Escherichia coli ribosomal pre-translocation complex assessed as stabilization of classical-state occupancy by tRNA at 200 uM2010Nature chemical biology, Jan, Volume: 6, Issue:1
Aminoglycoside activity observed on single pre-translocation ribosome complexes.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (665)

TimeframeStudies, This Drug (%)All Drugs %
pre-1990606 (91.13)18.7374
1990's19 (2.86)18.2507
2000's20 (3.01)29.6817
2010's16 (2.41)24.3611
2020's4 (0.60)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials8 (1.11%)5.53%
Reviews19 (2.64%)6.00%
Case Studies3 (0.42%)4.05%
Observational0 (0.00%)0.25%
Other691 (95.84%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]